Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands

de Jager, V.D.; Cajiao Garcia, B.N.; Kuijpers, C.C.H.J.; de Bock, G.H.; Maas, W.J.; Timens, W.; van Kempen, L.C.; van der Wekken, A.J.; Schuuring, E.; Willems, S.M.

doi:10.1016/j.ejca.2024.114125

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands

Cited by 3 publications

References 10 publications

Development and application of solid phase microextraction tips (SPME LC tips) method for therapeutic drug monitoring of gefitinib by LC-MS/MS

Development and application of solid phase microextraction tips (SPME LC tips) method for therapeutic drug monitoring of gefitinib by LC-MS/MS

Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report

Development and Application of Solid Phase Microextraction Tips (Spme Lc Tips) Method for Therapeutic Drug Monitoring of Gefitinib

Contact Info

Product

Resources

About